MethylBERT: A Transformer-based model for read-level DNA methylation pattern identification and tumour deconvolution Y Jeong, C Gerhäuser, G Sauter, T Schlomm, K Rohr, P Lutsik bioRxiv, 2023.10. 29.564590, 2023 | 1 | 2023 |
Selective arm-usage of pre-miR-1307 dysregulates angiogenesis and contributes to breast cancer aggressiveness OE Sumer, K Schelzig, J Jung, X Li, J Moros, L Schwarzmüller, E Sen, ... | | 2023 |
DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsy M Manoochehri, N Borhani, C Gerhäuser, Y Assenov, M Schönung, ... International Journal of Cancer 152 (5), 1025-1035, 2023 | 22 | 2023 |
Epigenetik von Tumoren D Weichenhan, DB Lipka, O Popanda, P Schmezer, C Gerhäuser, ... Kompendium Internistische Onkologie: Standards in Diagnostik und Therapie, 1-7, 2022 | | 2022 |
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation G Llimos, V Gardeux, U Koch, JF Kribelbauer, A Hafner, D Alpern, Pezoldt, ... Nature Communications 13 (1), 2042, 2022 | 6 | 2022 |
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients M Manoochehri, T Hielscher, N Borhani, C Gerhäuser, O Fletcher, ... Clinical Epigenetics 13, 1-11, 2021 | 4 | 2021 |
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples MH Bailey, WU Meyerson, LJ Dursi, LB Wang, G Dong, WW Liang, ... Nature communications 11 (1), 1-27, 2020 | 41 | 2020 |
Sex differences in oncogenic mutational processes CH Li, SD Prokopec, RX Sun, F Yousif, N Schmitz, ... Nature communications 11 (1), 1-24, 2020 | 67 | 2020 |
Combination Cancer Chemoprevention by Targeting the Epigenome C Gerhauser Natural Products for Cancer Chemoprevention 18, 577-612, 2020 | 1 | 2020 |
The Chemopreventive Power of Isothiocyanates S Dayalan Naidu, L Brodziak-Jarosz, C Gerhäuser, AT Dinkova-Kostova Natural Products for Cancer Chemoprevention 9, 271-318, 2020 | 2 | 2020 |
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis J Carlevaro-Fita, A Lanzós, L Feuerbach, C Hong, D Mas-Ponte, ... Communications biology 3 (1), 56, 2020 | 165 | 2020 |
Genomic footprints of activated telomere maintenance mechanisms in cancer L Sieverling, C Hong, SD Koser, P Ginsbach, K Kleinheinz, B Hutter, ... Nature communications 11 (1), 733, 2020 | 105 | 2020 |
Inferring structural variant cancer cell fraction M Cmero, K Yuan, CS Ong, J Schröder, NM Corcoran, T Papenfuss, ... Nature communications 11 (1), 730, 2020 | 37 | 2020 |
Combined burden and functional impact tests for cancer driver discovery using DriverPower S Shuai, S Gallinger, LD Stein Nature communications 11 (1), 734, 2020 | 37 | 2020 |
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations Y Zhang, F Chen, NA Fonseca, Y He, M Fujita, H Nakagawa, Z Zhang, ... Nature communications 11 (1), 736, 2020 | 63 | 2020 |
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns W Jiao, G Atwal, P Polak, R Karlic, E Cuppen, A Danyi, J De Ridder, ... Nature communications 11 (1), 728, 2020 | 181 | 2020 |
Integrative pathway enrichment analysis of multivariate omics data M Paczkowska, J Barenboim, N Sintupisut, NS Fox, H Zhu, D Abd-Rabbo, ... Nature communications 11 (1), 735, 2020 | 140 | 2020 |
Pathway and network analysis of more than 2500 whole cancer genomes MA Reyna, D Haan, M Paczkowska, LPC Verbeke, M Vazquez, ... Nature communications 11 (1), 729, 2020 | 95 | 2020 |
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig Y Rubanova, R Shi, CF Harrigan, R Li, J Wintersinger, N Sahin, ... Nature communications 11 (1), 731, 2020 | 45 | 2020 |
Divergent mutational processes distinguish hypoxic and normoxic tumours V Bhandari, CH Li, RG Bristow, PC Boutros Nature communications 11 (1), 737, 2020 | 106 | 2020 |